NKTR & opioids

The maker of the painkiller OxyContin will stop actively marketing its opioid products to doctors.

Purdue Pharmaceuticals announced that it would cut its sales staff by more than half and would stop sending sales representatives to doctor’s offices to discuss opioid products.

“We have restructured and significantly reduced our commercial operation and will no longer be promoting opioids to prescribers,” the company said in a statement.


I have to wonder how NKTR marketing will go over. Sure, they are not Purdue Pharma (as far as we know), but still curious how in the world theyre going to market their analgesic in today’s environment.